POSTOPERATIVE VISUAL LOSS

👀 Corneal abrasion is the most common ocular complication after general anesthesia

👀 Ischemic Optic neuropathy (ION) and Central Retinal Artery Occlusion (CRAO) are the commonest causes for postoperative visual loss

👀 ISCHEMIC OPTIC NEUROPATHY (ION)

🌵More common among the two

🌵Most often seen after prolonged surgery in prone position 

🌵Venous congestion--> Raised Intra Ocular Pressure (IOP) due to Raised Intra Orbital Pressure --> Intra Orbital ‘Compartment Syndrome’

🌵Hypotension, Diabetes, Vascular disease, Smoking etc also may be important in the etiopathogenesis

🌵Treatment:

➖ Reduce optic nerve edema as it passes through posterior scleral foramen with steroids and mannitol 

➖ Optimal oxygen delivery by ensuring normal blood pressure and hematocrit  

➖ Clear all obstruction to venous drainage 

🌵Chance of visual recovery is less

👀 CENTRAL RETINAL ARTERY OCCLUSION (CRAO)

🌵 External pressure on eye and embolism are risk factors 

🌵 An echocardiogram and carotid ultrasound may help us to find an embolic source

Reference: White E, David DB. Care of the eye during anaesthesia and intensive care. Anaesth Intens Care Med. 2007; 8(9): 383–386.

SUGAMMADEX & DRUG INTERACTIONS

Sugammadex acts by forming a complex with steroidal Neuro Muscular Blocking Agents such as rocuronium and vecuronium and reduces their concentrations in the neuromuscular junction. 

Because of its inert structure, direct drug interactions are rarely expected with sugammadex. Two types of drug interactions may occur with sugammadex by displacement or capturing.

Drugs interacting with sugammadex by displacement : toremifene, fusidic acid, and flucloxacillin, could potentially affect the efficacy of sugammadex due to rocuronium 

or vecuronium being displaced from sugammadex.

Capturing interactions may occur if sugammadex binds with other drugs (i.e., hormonal contraceptives), and reduces their free plasma concentration. In addition, sugammadex might have decreased efficacy for rocuronium or vecuronium due to it binding with another 

drug.

Cyclodextrins have been reported to form inclusion complexes with other compounds.

In an in vitro experimental model of functionally innervated human muscle cells Rezonja et al. found that dexamethasone led to a dose-dependent inhibition of sugammadex reversal; but Ersel Gulec et al, who investigated the clinical relevance of the interaction between dexamethasone and sugammadex in humans failed to demonstrate any inhibitory effect of dexamethasone (0.5 mg/kg) on the reversal time of sugammadex in children.

N.B.(DO YOU KNOW?): It is clearly demonstrated that dexamethasone attenuates rocuronium-induced neuromuscular blockade when administered 2 to 3 hours before the induction of anesthesia; but not when dexamethasone is given at induction

Reference: The Effect of Intravenous Dexamethasone on Sugammadex Reversal Time in Children Undergoing Adenotonsillectomy; Ersel Gulec, Ebru Biricik, Mediha Turktan, Zehra Hatipoglu and Hakki Unlugenc, April 2016 • Volume 122 • Number 4, anesthesia-analgesia